tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Reni Benjamin - 128 which are a Buy (95.52%), 6 which are a Hold (4.48%)
Analyst Reni Benjamin works at JMP and is covering the Healthcare sector with 229 price targets and ratings displayed on 22 stocks. Previously, Reni Benjamin worked at RAYMOND JAMES.
Reni Benjamin's average stock forecast success ratio is 39.01% with an average time for price targets to be met of 101.52 days.
Most recent stock forecast was given on INBX, Inhibrx at 20-Nov-2023.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA) at 3/2/2022. The price target of $5 was fulfilled within 23 days with a profit of $1.63 (48.37%) receiving and performance score of 21.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
40
$25.05 (167.56%)
42
1 months 2 days ago
0/5 (0%)
$19.15 (86.39%)
Buy
44
$29.05 (194.31%)
44
2 months 23 days ago
0/6 (0%)
$22.9 (78.79%)
Buy
2 months 23 days ago
0/3 (0%)
$33.27 (65.08%)
Hold
33
$18.05 (120.74%)
33
2 months 24 days ago
1/6 (16.67%)
$14.62 (37.19%)
13
Buy
57
$36.91 (183.72%)
57
4 months 1 days ago
3/8 (37.5%)
$21.13 (87.61%)
146
Which stock is Reni Benjamin is most bullish on?
Which stock is Reni Benjamin is most reserved on?
What Year was the first public recommendation made by Reni Benjamin?
